Erythropoietin Blockade Inhibits the Induction of Tumor Angiogenesis and Progression

BACKGROUND: The induction of tumor angiogenesis, a pathologic process critical for tumor progression, is mediated by multiple regulatory factors released by tumor and host cells. We investigated the role of the hematopoietic cytokine erythropoietin as an angiogenic factor that modulates tumor progre...

Descripción completa

Detalles Bibliográficos
Autores principales: Hardee, Matthew E., Cao, Yiting, Fu, Ping, Jiang, Xiaohong, Zhao, Yulin, Rabbani, Zahid N., Vujaskovic, Zeljko, Dewhirst, Mark W., Arcasoy, Murat O.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1891087/
https://www.ncbi.nlm.nih.gov/pubmed/17579721
http://dx.doi.org/10.1371/journal.pone.0000549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1891087/
https://www.ncbi.nlm.nih.gov/pubmed/17579721
http://dx.doi.org/10.1371/journal.pone.0000549

Ejemplares similares